首页> 外文期刊>BMC Complementary and Alternative Medicine >Prevention of acute radiation-induced Proctitis by Aloe vera : a prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients
【24h】

Prevention of acute radiation-induced Proctitis by Aloe vera : a prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients

机译:通过芦荟预防急性辐射诱导的前炎:盆腔癌患者的前瞻性随机,双盲,安慰剂对照临床试验

获取原文
           

摘要

Acute radiation-induced proctitis (ARP) is the most common side effect following radiotherapy for malignant pelvic disease. This study evaluated the efficacy of Aloe vera ointment in prevention of ARP. Forty-two patients receiving external-beam radiotherapy (RT) for pelvic malignancies were randomized to receive either Aloe vera 3% or placebo topical ointment during radiotherapy for 6?weeks. These patients were evaluated based on the severity (grade 0–4) of the following symptoms weekly: rectal bleeding, abdominal/rectal pain, diarrhea, or fecal urgency. RTOG acute toxicity criteria and psychosocial status of the patients were also recorded weekly. Lifestyle impact of the symptoms, and quantitative measurement of C-reactive protein (CRP), an indicator of systemic inflammation, were also measured. The results of present study demonstrated a significant preventive effect for Aloe vera in occurrence of symptom index for diarrhea (p??0.001), rectal bleeding (p??0.001), and fecal urgency (p?=?0.001). The median lifestyle score improved significantly with Aloe vera during RT (p??0.001). Intervention patients had a significant lower burden of systemic inflammation as the values for quantitative CRP decreased significantly over 6?weeks of follow-up (p?=?0.009). This study showed that Aloe vera topical ointment was effective in prevention of symptoms of ARP in patients undergoing RT for pelvic cancers. IRCT201606042027N6. Registration date: 2016-09-04.
机译:急性辐射诱导的前喉炎(ARP)是恶性骨盆疾病放射治疗后最常见的副作用。本研究评估了芦荟软膏在预防ARP的疗效。接受骨盆恶性肿瘤的外梁放射治疗(RT)的四十二次患者被随机化,以在放射治疗期间接受芦荟3%或安慰剂局部软膏6?周。这些患者是根据每周症状的严重程度(0-4级)评估:直肠出血,腹部/直肠疼痛,腹泻或粪便紧迫性。 RTOG急性毒性标准和患者的心理社会状况也在每周记录。还测量了症状的生活方式影响,以及C反应蛋白(CRP)的定量测​​量,是全身炎症的指标。目前研究的结果表明,芦荟对腹泻的症状指数发生的显着预防效果(p?<0.001),直肠出血(P?<0.001)和粪便紧迫性(P?= 0.001)。在室温期间,芦荟维拉中位的生活方式评分显着改善(p?<0.001)。由于定量CRP的价值显着降低了6〜30分钟(P?= 0.009),干预患者的系统性炎症负担显着降低。本研究表明,芦荟局部软膏可有效地预防骨盆癌患者中ARP的症状。 IRCT201606042027N6。注册日期:2016-09-04。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号